ArticleCurrent oncology (Toronto, Ont.)2023

Poor Efficacy of Immune Checkpoint Inhibitors Plus Chemotherapy in Lung Cancer Patients with EGFR/ERBB2 Exon 20 Insertion.

Yue Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.